Insulin price drop is good news. But people with diabetes need more.

Xavier Roger


Kimberly M. Baker

Novo Nordisk and Sanofi announced last week that they will lower prices on some of their insulin products by up to 78% effective January 2024. That follows Eli Lilly’s recent announcement that it will lower some of its insulin prices by 70% later this year.

My son – who was diagnosed with Type 1 diabetes, an autoimmune disease that destroys the body’s ability to make insulin – obtains his insulin from Novo Nordisk, and so this news brings significant financial relief for my family.


Source link

Leave a comment